Martin Traebert Person-Info 

( Ich bin Martin Traebert)

News

: CiPA Myocyte validation study now published in JPTM

www.nanion.de
Nanion Technologies - Smart Tools for Ion Channel Research

Screening Technology Challenges

www.genengnews.com
Martin Traebert, Ph.D., group head of in vitro safety pharmacology in preclinical development at Novartis Pharma described how hERG ...
Dossier exportieren
+1